Pulmonology

Radiation Oncology of Lung Cancer: Where Do We Stand?

Radiation Oncology of Lung Cancer: Where Do We Stand? – MM1401

Lung cancer continues to be the major cancer killer in both sexes world-wide. Approximately 1.6 million new cases of lung cancer are diagnosed each year. The overall cure rate from lung cancer is modest (approximately 17%) because majority of patients present with advanced stage at diagnosis. This is irrespective of refinements in histological aspects, better diagnostic and staging tools, including the massive influence of positron emission tomography (PET)
scanning, as well as a sharp shift towards molecular oncology already finding its way into clinical practice. Although there are many treatment modalities employed in lung cancer, radiation therapy (RT) is used in the majority of these, both for cure and palliation.

Modern Medicine – January 2014

Levofloxacin Still Effective in Treating Respiratory Tract Infections

Levofloxacin Still Effective in Treating Respiratory Tract Infections – MM1307

Community-acquired respiratory tract infections (RTIs) are among the most prevalent infectious diseases in the developed world and constitute a
substantial economic burden. The current therapy for RTIs is often empiric, usually involving administration of a betalactam or macrolide.

Modern Medicine – July 2013

Opening Up the Airways in Severely Problematic Lungs

Opening Up the Airways in Severely Problematic Lungs – MM1306

Problematic breathing and lung disease are on the increase, resulting in a loss of lifestyle quality and productivity for many. Chronic obstructive pulmonary disease (COPD) and asthma are just two of the 43 different respiratory diseases
affecting people. Appropriate treatment can restore a high degree of daily functioning and quality of life.

Modern Medicine – June 2013

Levofloxacin in the Treatment of Community-Acquired Pneumonia

Levofloxacin in the Treatment of Community-Acquired Pneumonia – MM1305

Fluoroquinolones are an increasingly important class of drugs for treating a wide range of infections, with ofloxacin being one of the most commonly used of these compounds. Levofloxacin, the l-isomer of ofloxacin, is twice as potent as its
parent compound, and therefore possesses all of the advantages offered by ofloxacin, as well as providing additional benefits.

Modern Medicine – May 2013

Verified by ExactMetrics